33
EUCAST definitions (and breakpoint table, MIC and zone distribution website conventions) Derek Brown ECCMID 2011, Milan

EUCAST 2012 Definitions Interpretations

Embed Size (px)

DESCRIPTION

EUCAST AST guidelines 2012

Citation preview

Page 1: EUCAST 2012 Definitions Interpretations

EUCAST definitions(and breakpoint table, MIC and

zone distribution website conventions)

Derek BrownECCMID 2011, Milan

Page 2: EUCAST 2012 Definitions Interpretations

Clinically susceptible/resistant

• A microorganism is defined as susceptible by a level of antimicrobial activity associated with a high likelihood of therapeutic success

• A microorganism is defined as resistant by a level of antimicrobial activity associated with a high likelihood of therapeutic failure.

Page 3: EUCAST 2012 Definitions Interpretations

Clinically intermediateA microorganism is defined as intermediate by a level of antimicrobial activity associated with uncertain therapeutic effect.

• It implies that an infection due to the isolate may be appropriately treated in body sites where the drugs are physically concentrated or when a high dosage of drug can be used

• (In susceptibility testing it also indicates a buffer zone that should prevent small, uncontrolled, technical variation from causing major discrepancies in interpretation)

Page 4: EUCAST 2012 Definitions Interpretations

Clinical breakpoints

• a microorganism is categorized as susceptible (S), intermediate (I) or resistant (R) by applying the appropriate breakpoint in a defined phenotypic test system

• MICs are the primary breakpoints• Breakpoints in other methods are correlated

with MIC breakpoints

Page 5: EUCAST 2012 Definitions Interpretations

Breakpoints and cut-off values

• Clinical breakpoints

• Non-species-related breakpoints

• Epidemiological cut-off value (ECOFF)

Page 6: EUCAST 2012 Definitions Interpretations

Non-species-related breakpoints

• Pk/Pd (pharmacokinetic/pharmacodynamic) breakpoints

• Used in clinical breakpoint development

• Can be a guide to interpretation in situations where there is no species-specific clinical breakpoint

Page 7: EUCAST 2012 Definitions Interpretations

Epidemiological cut-off value (ECOFF)

• MIC value identifying the upper limit of the wild type population

• A microorganism is defined as wild type (WT) for a species by the absence of acquired and mutational mechanisms of resistance to the agent.

Page 8: EUCAST 2012 Definitions Interpretations

EUCAST wild type and ECOFF

Wild type

ECOFF

Page 9: EUCAST 2012 Definitions Interpretations

EUCAST wild type and ECOFF

ECOFF

Wild type

Page 10: EUCAST 2012 Definitions Interpretations

Epidemiological cut-off values (ECOFFs)

• Estimated by visual inspection or statistically calculated (Turnidge et al CMI 2006;12:418-25)

• The ECOFF is not changed by sampling time, source (human, animal, environmental), geographical origin

• Used in clinical breakpoint development and as a sensitive indicator of resistance development in surveillance studies.

Page 11: EUCAST 2012 Definitions Interpretations

Relationship between the clinical breakpoints, non-species-related

breakpoints and ECOFFs• Non-species-related breakpoints will be same as

clinical breakpoints unless they split the wild type or there is no resistance

• There is no definitive relationship between clinical breakpoints and ECOFFs

Page 12: EUCAST 2012 Definitions Interpretations

Clinical breakpoint higher than ECOFF

ECOFF S breakpoint R breakpoint

Non-sp-related BP S R Non-sp-related BP

Page 13: EUCAST 2012 Definitions Interpretations

Clinical breakpoint same as ECOFF

ECOFF

S/I and R breakpoint

Non-sp-related BP S R Non-sp-related BP

Page 14: EUCAST 2012 Definitions Interpretations

Clinical breakpoint lower than ECOFF

ECOFF

S breakpoint R breakpoint

Non-sp-related BP S R Non-sp-related BP

Page 15: EUCAST 2012 Definitions Interpretations

ECOFF and zone diameters

ECOFF

Wild type

Page 16: EUCAST 2012 Definitions Interpretations

EUCAST breakpoint tables v 1.3

Page 17: EUCAST 2012 Definitions Interpretations

Highlight indicates change since last version

EUCAST breakpoint table notes

Page 18: EUCAST 2012 Definitions Interpretations

S ≤ , R >MIC R>4 mg/L ≡ ≥8 mg/LZone R<24mm ≡ ≤ 23 mm

EUCAST breakpoint format

S ≤1, R >4

Susceptible ResistantI

S ≤1, R ≥8

Susceptible ResistantI

12864321684210.5

Page 19: EUCAST 2012 Definitions Interpretations

EUCAST intermediate category

Intermediate category is not displayede.g. Ciprofloxacin S≤0.5 mg/L, R>1 mg/L,Intermediate inferred >0.5-1 mg/L

S ≥ 22 mm, R<18 mm,Intermediate inferred 18-21 mm

Page 20: EUCAST 2012 Definitions Interpretations

“-” Susceptibility testing not recommended as the species is a poor target for therapy with the drug(do not test, or do not report, orreport as R)

EUCAST table abbreviations

“IE” Insufficient evidence to set a breakpoint (report MIC values with comment but no categorical interpretation)

Page 21: EUCAST 2012 Definitions Interpretations

“NA” Not Applicable (used for screening tests when they are not applicable to particular organisms)

EUCAST table abbreviations

“IP” In preparation (breakpoints will be established)

Page 22: EUCAST 2012 Definitions Interpretations

Click on antibiotic for Rationale Document

EUCAST breakpoint table links to rationale documents

Page 23: EUCAST 2012 Definitions Interpretations

Click on MIC breakpoint for MIC distributions

EUCAST breakpoint table links to MIC distributions

Page 24: EUCAST 2012 Definitions Interpretations

Click on zone breakpoint for zone diameter distributions

EUCAST breakpoint table links to zone diameter distributions

Page 25: EUCAST 2012 Definitions Interpretations

EUCAST website (www.EUCAST.org)

Page 26: EUCAST 2012 Definitions Interpretations

EUCAST MIC and zone diameter distributions website

Page 27: EUCAST 2012 Definitions Interpretations

EUCAST MIC and zone distributions

Select MIC or zone diameter distribution

Select agent or species

Page 28: EUCAST 2012 Definitions Interpretations

Blue indicates wild type

Clinical breakpoints and ECOFF

Link to graph

EUCAST MIC and zone distributions

Page 29: EUCAST 2012 Definitions Interpretations

EUCAST MIC distributions

Do not infer resistance rates

May include truncated distributions

Page 30: EUCAST 2012 Definitions Interpretations

EUCAST MIC distributionsInsufficient data to define ECOFF

Page 31: EUCAST 2012 Definitions Interpretations

EUCAST zone diameter distributions

Page 32: EUCAST 2012 Definitions Interpretations

EUCAST MIC-zone diameter correlation

Page 33: EUCAST 2012 Definitions Interpretations

Summary

• EUCAST provides clinical breakpoints, non-species-related breakpoints and epidemiological cut-off values (ECOFF)

• Be aware of formatting conventions and abbreviations in EUCAST breakpoint tables and on EUCAST MIC and zone diameter distributions website

www.EUCAST.org